Data-Science-led Services for Pharma
Elevate your drug development efficacy and commercialization success when you partner with Cytel. We integrate cutting-edge analytical methods and tailored strategies to streamline your processes and ensure successful market transitions.
Harness the Power of Data Science and Analytical Methods
In the competitive landscape of pharmaceutical development, companies face the dual challenges of accelerating drug development and ensuring market success under stringent regulatory scrutiny. Cytel empowers your journey with sophisticated statistical insights and strategic guidance, tailored to meet complex pharmaceutical needs. We specialize in transforming challenges into opportunities, applying innovative trial designs and comprehensive data strategies to enhance efficiency and inform decision-making. Our solutions are designed to reduce time-to-market and optimize outcomes, ensuring that your products not only achieve regulatory approval but also realize their commercial potential.
Pioneering Strategies to Drive Better Insights
Beyond Standard FSP with Analytics on Demand
Our flexible, on-demand statistical expertise will enhance your team's capabilities for faster, more confident decision-making.
Axio® Data Monitoring Committees
We offer independent oversight to safeguard the integrity of your trials and ensure patient safety, crucial for both regulatory approval and public trust.
Complex Innovative Designs
Our adaptive designs and advanced statistical models reduce trial durations and costs while enhancing the adaptability and success rate of your clinical studies.
Real-World Evidence and Data Solutions
We provide you with a better understanding of your drug's performance in real-world settings, crucial for regulatory success and optimal market positioning.
Biostatistical Services
We deliver robust statistical analyses to underpin all phases of clinical development, ensuring scientifically sound conclusions that support regulatory and commercial strategy.
Market Access and Payer Endpoint Validation
We develop strategies to ensure that your products meet payer expectations, crucial for achieving broad market access and favorable reimbursement.
Streamline Decisions with our Functional Service Provider Services
Cytel’s Analytics on Demand services, our expanded FSP solutions, provides pharmaceutical companies with scalable statistical expertise, crucial for adapting to the evolving requirements of drug development. This service ensures that your team can swiftly respond to new data, make pivotal decisions on the go, and maintain momentum without compromising on quality or accuracy. The outcome? Reduced delays and a more streamlined pathway to achieving milestones, ultimately enhancing the drug’s speed to market and your competitive edge in the pharmaceutical landscape.
Learn MoreEstablish Integrity with Axio® Data Monitoring Committees
Axio® Data Monitoring Committee services are integral to maintaining the highest standards of clinical trial conduct. By providing independent, expert oversight, Axio ensures that your clinical trials are not only compliant with global regulatory standards but also aligned with best practices for patient safety. This rigorous process helps to minimize risk, protect patient welfare, and enhance the credibility of your trial results, which are critical for successful regulatory reviews and sustained market confidence.
Learn More
Leverage Real-World Insights for Market Success
Cytel’s real-world evidence (RWE) and data (RWD) solutions harness the power of post-market data to support ongoing regulatory requirements and market strategy adjustments. By integrating RWE into your development strategy, Cytel helps demonstrate the long-term value and effectiveness of your products, facilitating smoother regulatory updates and broader market acceptance. This approach not only supports successful initial market entry but also bolsters efforts for label expansions and market adaptation based on emerging health outcomes and patient needs.
Learn MoreAdvance Your Drug Development with Innovative Designs
Cytel’s complex innovative designs, including adaptive methodologies and seamless trial integration, are designed to optimize your clinical trial processes. These methodologies allow for flexibility in study conduct, rapid adjustments based on interim data, and enhanced resource utilization. The result is a significant reduction in development time and costs, increased adaptability to clinical findings, and a higher probability of trial success. This strategic advantage is crucial if you’re looking to innovate effectively and maintain a competitive edge in a rapidly evolving industry.
Learn More
50%
Of Phase III clinical trials fail due to inadequate efficacy or safety
80%
Of new drugs fail to meet pre-launch sales expectations, with market access restrictions as a major factor.
20%
Of new drug applications include some form of adaptive design
>60%
Of pharma companies regularly use RWE to support regulatory decisions and expand labeling, which improves the drug’s market potential and patient access.
Claim your free 30-minute strategy session
Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug's probability of success and plot a clearer route to market.
